GlassScriptPhysician profile
Mallory Clark
NPI 1659750545
$1,295.63
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $657 · 2020: $422 · 2021: $99.53 · 2023: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $117.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $173.85 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $167.17 | 2019-2021 | |
| Abbott Laboratories | $140.84 | 2019 | |
| Pfizer INC. | $104.72 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $104.64 | 2019-2023 | Lifevest |
| Vifor Pharma, INC. | $83.67 | 2020 | |
| Janssen Pharmaceuticals, INC | $82.03 | 2019 | |
| Portola Pharmaceuticals, LLC | $69.53 | 2020 | |
| Paratek Pharmaceuticals, INC. | $58.15 | 2020-2023 | Nuzyra |
| Melinta Therapeutics, LLC | $50.82 | 2020 | |
| Pharmacosmos Therapeutics INC. | $48.58 | 2021 | |
| Abbvie INC. | $32.27 | 2023 | Dalvance |
| E.R. Squibb & Sons, L.L.C. | $25.94 | 2020 | |
| Alexion Pharmaceuticals, INC. | $23.91 | 2019 | |
| Bioxcel Therapeutics, INC. | $21.62 | 2023 | Igalmi |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $21.58 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.26 | 2020 | |
| Ferring Pharmaceuticals INC. | $20.87 | 2023 | Rebyota |
| Merck Sharp & Dohme LLC | $14.91 | 2019 | |
| Novo Nordisk INC | $14.64 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mallory Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.